Skip to main content

Table 1 Basal characteristics of patients

From: Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer

Patient Characteristics

N = 42

Overall median follow up period (months, range)

28.7 (8.4-49.1)

Age (years, mean ± SD)

60.1 ± 10.9

Sex (male/female)

32/10

Cause of HCC (HBV/HCV/Alcohol/Others)

29/7/2/4

ECOG performance (0/1)

41/1

Child-Pugh classification (A/B/C)

38/4/0

AJCC stage (I/II/IIIa/IV)

23/16/3/0

Median tumor volume (cc, range)

15.4 (3.04-81.82)

Tumor number (solitary/multifocal)

27/15

Initial median AFP (ng/dl, range)

13.9 (1.0-798.8)

Previous therapy

 

No treatment

8

TACE alone

16

TACE combined with locoregional therapies

16 (PEI 13, RFA 3)

TACE combined with surgical resection

2

  1. Abbreviations: HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; ECOG performance, Eastern Co-operative Group performance; AFP, alfa-fetoprotein; TACE, transarterial chemoembolization; PEI, percutaneous ethanol injection; RFA, radiofrequency ablation